Nobody in this "new" any experience at all in dealing with in dealing with the FDA during a pandemic or in getting an EUA for a therapeutic like leronlimab. Only the present management has ever dealt with a situation at this level. Against all odds they have made substantial progress, against a very powerful agency aligned against it. This new group has failed us in the past. It has no record of success or experience in the situation faced by CYDY. Please name a single BLA or EUA they have ever obtained that is any near the consequence of what present management is trying to achieve. They would most likely set the company back two years as they obviously are dissatisfied with the progress achieved. All this is my humble opinion except for the obvious facts which are being distorted by some. We must stay the course, as painful as it may be to our economic concerns,
for the sake of humanity.